According to Nova One Advisor, the global infection control market size was estimated at $227.21 billion in 2024 and is expected to hit around $438.67 billion by 2034, poised to grow at a CAGR of 6.8% from 2024 to 2034.
The technological advancements in sterilization techniques, conduction of clinical trials for infection control, increasing need for battling antibiotic resistance and the rising incidences of hospital-acquired infections are driving the growth of the infection control market.
North America dominated the infection control market and accounted for the largest revenue share of over 31% in 2024. The growth of this region can be attributed to various factors such as the active implementation of policies and practices for preventing spread of infections in hospitals and communities. Furthermore, the monitoring of potential outbreaks by healthcare facilities, promotion of antimicrobial stewardship programs, well-established healthcare infrastructure, strategies for battling drug resistant organisms and precautionary measures taken for preventing potential pandemics.
The U.S. dominated the infection control market in North America. The stringent government policies and strategies for public safety against infections, guidelines implemented by the Centers for Disease Control (CDC) for evaluating infections and controlling them are driving market growth.
The Asia Pacific region is expected to grow rapidly over the forecast period. The rising government focus on implementing infection control policies, increasing healthcare expenditure, adoption of advanced technologies for infection control, growing public awareness, comprehensive training programs for healthcare providers and the ongoing developments in innovative technologies and drugs for infection control are contributing to the growth in this region. Furthermore, in July 2024, the Asia Pacific Society of Infection Control (APSIC) hosted an international conference in Indonesia for infection prevention and control illustrating the region’s readiness towards implementing infection control programs.
Furthermore, there is a rising awareness among people regarding rising infection rates and sudden outbreaks, surge in hospital-acquired infections, stringent regulations by government for infection control standards, novel innovations with advancements in sterilization and infection control techniques.
The digitalization of sterile processing helps in automating processes with improved tracking of medical devices, reducing human errors and implementing software for digital case management that will ultimately enhance the efficacy with reduced costs. Also, it significantly mitigates risk of infections thereby streamlining processes with improved quality of patient care
The integration of artificial intelligence (AI) in infection control can aid in early detection and efficient surveillance of potential outbreaks, patient risk stratification, optimizing hand hygiene practices, identifying potential contamination sources by analyzing data through environmental monitoring systems and to prevent healthcare-associated infections (HAIs) which will eventually lead to improved patient safety and healthcare quality while mitigating the infection risks.
The hospital segment dominated the market for infection control and accounted for the largest revenue share of around 41% in 2024 and is also expected to grow at the fastest CAGR of 7.4% over the forecast period from 2024 to 2034.
A PRNewswire report citing MarketsandMarkets also predicts continued market growth.
The global infection control market, valued at $54.32 billion in 2024, stood at $57.31 billion in 2025 and is projected to advance at a resilient CAGR of 6.3% from 2025 to 2030, culminating in a forecasted valuation of $77.67 billion by the end of the period, the report states.
The infection control market is experiencing significant growth driven by several key factors. The rising prevalence of healthcare-associated infections (HAIs) and the increasing number of surgical procedures underscore the critical need for effective infection prevention strategies. Advancements in reprocessing technologies enhance the efficiency and safety of sterilization processes, while the growing emphasis on sterilizing and disinfecting food products addresses public health concerns. Innovations in sterilization equipment technology further improve outcomes by offering more reliable and advanced solutions. Additionally, the growing trend of outsourcing services among pharmaceutical companies, medical device manufacturers and hospitals reflects a strategic shift towards specialized infection control expertise, collectively fueling market expansion.
